Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study.
Authors
Pugh, SBowers, M
Ball, A
Falk, S
Finch-Jones, M
Valle, Juan W
O'Reilly, D
Siriwardena, A
Hornbuckle, J
Rees, M
Rees, C
Iveson, T
Hickish, T
Maishman, T
Stanton, L
Dixon, E
Corkhill, A
Radford, M
Garden, O J
Cunningham, D
Maughan, T
Bridgewater, J
Primrose, J
Affiliation
University Surgery and Cancer Sciences Division, University of Southampton, Southampton General Hospital, Southampton SO16 6YDIssue Date
2016-08-09
Metadata
Show full item recordAbstract
The addition of cetuximab (CTX) to perioperative chemotherapy (CT) for operable colorectal liver metastases resulted in a shorter progression-free survival. Details of disease progression are described to further inform the primary study outcome.Citation
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study. 2016, 115 (4):420-4 Br. J. CancerJournal
British Journal of CancerDOI
10.1038/bjc.2016.208PubMed ID
27434036Type
ArticleLanguage
enISSN
1532-1827ae974a485f413a2113503eed53cd6c53
10.1038/bjc.2016.208
Scopus Count
Collections
Related articles
- Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases.
- Authors: Ye LC, Liu TS, Ren L, Wei Y, Zhu DX, Zai SY, Ye QH, Yu Y, Xu B, Qin XY, Xu J
- Issue date: 2013 Jun 1
- Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials.
- Authors: Moretto R, Corallo S, Belfiore A, Rossini D, Boccaccino A, Lonardi S, Centonze G, Morano F, Germani MM, Loupakis F, Morelli L, Urbani L, Brich S, Marmorino F, Prisciandaro M, Aprile G, Fassan M, Cillo U, Cattaneo L, Fontanini G, De Braud F, Falcone A, Milione M, Pietrantonio F, Cremolini C
- Issue date: 2020 Aug
- Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases.
- Authors: Pietrantonio F, Di Bartolomeo M, Cotsoglou C, Mennitto A, Berenato R, Morano F, Coppa J, Perrone F, Iacovelli R, Milione M, Alessi A, Vaiani M, Bossi I, Ricchini F, Scotti M, Caporale M, Bajetta E, de Braud F, Mazzaferro V
- Issue date: 2017 Sep
- [Recent results of irinotecan therapy in colorectal cancer].
- Authors: Láng I, Hitre E
- Issue date: 2004
- Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab.
- Authors: Basso M, Dadduzio V, Ardito F, Lombardi P, Strippoli A, Vellone M, Orlandi A, Rossi S, Cerchiaro E, Cassano A, Giuliante F, Barone C
- Issue date: 2016 May